Publication | Closed Access

Nerve growth factor metabolic dysfunction contributes to sevoflurane-induced cholinergic degeneration and cognitive impairments

Sevoflurane-induced Cholinergic DegenerationNeurophysiologyPhysiologyCognitive ImpairmentsBrain InjuryNeuroscienceNeuroprotectionNeurologyMedicineNeurochemistrySocial SciencesNeuroinflammation